A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group
PLOS Neglected Tropical Diseases · 2024
DOI: 10.1371/journal.pntd.0012562 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2024. Verfasst von Dallas J Smith und 21 weiteren Autor:innen. Beteiligte Einrichtung: Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. Hauptthemen laut MEDLINE: Chromoblastomycosis, Neglected Diseases, Global Health. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: World Health Organization.
Abstract (Originalsprache)
Chromoblastomycosis, an implantation mycosis, is a neglected tropical disease that causes decreased quality of life, stigma, and disability. The global burden of disease is unknown and data on disease epidemiology and outcomes are severely limited by a lack of access to needed diagnostic tools and therapeutics. The World Health Organization outlined targets for chromoblastomycosis in the Road Map for Neglected Tropical Diseases 2021–2030, but little progress has been made in initiating and implementing an effective control program globally. This lack of guiding policy and progress led to the recent formation of a Global Chromoblastomycosis Working Group which has developed a global chromoblastomycosis strategy. We describe this strategy, which outlines specific steps needed to improve technical progress, strategy and service delivery, and enablers. Clinicians, researchers, public and government officials, patients, and policy makers can align their time, expertise, and resources to improve the lives of communities affected by chromoblastomycosis through this strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
- Department of Public Health, Federal University of Paraná, Curitiba, Brazil.
- LARTIC Laboratory, Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar.
- King's College London, London, United Kingdom.
- Servicio de Dermatología, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico.
- Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia.
ORCID-Profile: Dallas J Smith
Förderung
- World Health Organization
Zitieren
APA
Smith, D. J., Queiroz-Telles, F., Rabenja, F. R., Hay, R., Bonifaz, A., Grijsen, M. L., Blaizot, R., Messina, F., Song, Y., Lockhart, S. R., Jordan, A., Cavanaugh, A. M., Litvintseva, A. P., Chiller, T., Schito, M., de Hoog, S., Vicente, V. A., Cornet, M., Dagne, D. A., …, & Santos, D. W. C. L. (2024). A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012562
Vancouver
Smith DJ, Queiroz-Telles F, Rabenja FR, Hay R, Bonifaz A, Grijsen ML, et al. A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group. PLOS Neglected Tropical Diseases. 2024. doi:10.1371/journal.pntd.0012562
BibTeX
@article{Smith2024,
author = {Smith, Dallas J and Queiroz-Telles, Flávio and Rabenja, Fahafahantsoa Rapelanoro and Hay, Roderick and Bonifaz, Alexandro and Grijsen, Marlous L and Blaizot, Romain and Messina, Fernando and Song, Yinggai and Lockhart, Shawn R and Jordan, Alexander and Cavanaugh, Alyson M and Litvintseva, Anastasia P and Chiller, Tom and Schito, Marco and de Hoog, Sybren and Vicente, Vania Aparecida and Cornet, Muriel and Dagne, Daniel Argaw and Ramarozatovo, Lala S and de Azevedo, Conceição de Maria Pedrozo E Silva and Santos, Daniel Wagner C L},
title = {A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group},
journal = {PLOS Neglected Tropical Diseases},
year = {2024},
doi = {10.1371/journal.pntd.0012562}
}
EUVIMED